Sarcoma  >>  ifosfamide  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ifosfamide / Generic mfg.
NCT03283696: A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Completed
1b
24
Europe, US
Olaratumab, LY3012207, Doxorubicin, Ifosfamide, Mesna
Eli Lilly and Company
Soft Tissue Sarcoma
04/19
08/19
NCT00358540: Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Completed
1
18
US
eltrombopag
GlaxoSmithKline
Thrombocytopaenia
10/10
10/10
NCT00960063: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Terminated
1
4
NA
Temozolomide, Vincristine, Ifosfamide, Irinotecan, Robatumumab, Doxorubicin, Cyclophosphamide, Etoposide
Merck Sharp & Dohme LLC
Neoplasms, Solid Tumors, Bone Cancer, Kidney Tumor, Neuroblastoma
12/10
12/10
NCT06156410: Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma

Recruiting
1
30
US
Cabozantinib
Children's Hospital of Philadelphia, Children's Hospital Colorado, Exelixis, Alex's Lemonade Stand Foundation
Ewing Sarcoma, Osteosarcoma
11/27
11/28

Download Options